Roche's Brain Shuttle Alzheimer's Drug Trontinemab Enters 1,600-Person Prevention Trial as Brain Scans Test Delivery Claims
Roche has begun enrolling 1,600 cognitively healthy adults with Alzheimer's biomarkers in a phase 3 trial of trontinemab, while new scans assess how the drug reaches the brain.
Medical Daily ·